Table of Contents
South African-born billionaire and cancer treatment innovator Patrick Soon-Shiong has experienced a remarkable surge in his net worth, accumulating $540 million in just two weeks — thus pushing his year-to-date wealth gains above $1 billion.
According to the Bloomberg Billionaires Index — which tracks the fortunes of the world’s top 500 billionaires — Soon-Shiong’s net worth has increased by an impressive $540 million in the last 14 days, climbing to $9.97 billion on Nov. 27 from $9.43 billion on Nov. 13.
This recent surge in his fortune translates to an average daily gain of $38.5 million since Nov. 13, propelling him closer to the $10 billion milestone and further solidifying his status as one of Africa’s wealthiest billionaires.
Patrick Soon-Shiong’s $1.04 billion comeback in global healthcare
Earlier this year, Soon-Shiong faced a challenging period, with his fortune plummeting by millions of dollars. However, thanks to the sustained increase in his fortune, the recent gain of $540 million has driven his year-to-date gain to $1.04 billion as of report writing.
His year-to-date wealth gains underscore his influential role, as he stands renowned for his groundbreaking contributions to cancer treatment in the global healthcare sector against the odds of market challenges.
At the time of drafting this report, Soon-Shiong holds the position of the 213th wealthiest individual globally. He trails American billionaire Tilman Fertitta, the chairman and chief executive of Fertitta Entertainment.
Patrick Soon-Shiong’s 80-percent ImmunityBio stake powers billion-dollar resurgence
One of the key contributors to Soon-Shiong’s billion-dollar fortune is his 80-percent majority stake in ImmunityBio, a late-stage immunotherapy company at the forefront of developing cutting-edge cell and immunotherapy products.
Soon-Shiong’s financial resurgence not only showcases his entrepreneurial prowess but also reaffirms his position in healthcare and biotechnology — his contributions to cancer treatment and innovative ventures continue to shape the global healthcare landscape, making him a notable figure in the industry.
